23
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Sensitivity to Anti-tuberculosis Drugs in HIV-positive and -negative Patients in Addis Ababa

Pages 914-919 | Published online: 08 Jul 2009

  • Nunn P, Felton M. Surveillance of resistance to anti tuberculosis drugs in developing countries. Tuberc Lung Dis 1994; 75: 163–7.
  • Dias E, Ghebre Michael S, Hoffener SE. Drug susceptibility in mycobacterium tuberculosis of a sample of patients in GuineaBissau. Tuberc Lung Dis 1993; 74: 129–30.
  • Valenzuela MT, Garcia P, Ponce J, et al. Drug resistance of M tuberculosis in Chile. Bull Int Union Tuberc 1989; 64: 13–4.
  • Overcoming anti-microbial resistance. http://www.who.int/infectious-disease report/2000ch3.htm.
  • Drug resistance threatens to reverse medical progress. Press Release WHO/41. http://www.who.int/inf-pr-2000/en/pr2000-41.html
  • Ministry of Health of Ethiopia. AIDS in Ethiopia, 2nd edn. Addis Ababa: Ministry of Health, 1998.
  • Ministry of Health of Ethiopia. Manual for national tuberculosis and leprosy control programme. Addis Ababa: Ministry of Health, 1997.
  • Gellete A, Kebede D, Berhane Y. Tuberculosis and HIV infection in Southern Ethiopia. Ethiop J Health Dev 1997; 11: 51–9.
  • Demissie M, Lindtjorn B, Tegbaru B. Prevalence of human immuno deficiency virus infection in tuberculosis patients in Addis Ababa. Ethiop J Health Dev 2000; 14: 277–82.
  • Abate G, Miorner H, Ahmed O, Hoffner SE. Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: Susceptibility to first line and alternative drugs. Int J Tuberc Lung Dis 1998; 2: 580–4.
  • Mitike G, Kebede D, Yeneneh H. HIV infection and anti tuberculosis drug resistance among pulmonary tuberculosis patients in Harar tuberculosis centre, Ethiopia. East Afr Med J 1997; 74: 154–7.
  • Lemma E, Jose A, Alvarez V, Gebre Tsadik G. Drug sensitivity pattern on Mycobacterium tuberculosis isolated in Addis Ababa. Ethiop Med J 1984; 22: 93–6.
  • Wolde K, Lemma E, Abdi A. Primary resistance to the major anti tuberculosis drug in Ethiopia. Ethiop Med J 1986; 24: 15–8.
  • Lemma E, Niemi M, Lindtjorn B. Bacteriological studies of tuberculosis in Sidamo Regional Hospital. Ethiop Med J 1989; 27: 147–9.
  • Demissie M, Gebeyehu M, Berhane Y. Primary resistance to anti tuberculosis drug in Addis Ababa, Ethiopia. Int J Tuberc Lung Dis 1997; 1: 64–7.
  • Asch A, Knowles L, Rai A, et al. Relationship of isoniazid resistance to human immuno deficiency virus infection in patients with tuberculosis. Am J Respir Crit Care Med 1996; 153: 1708–10.
  • Gordin FM, Nelson ET, Matts JP, et al. The impact of human immuno deficiency virus in drug resistant tuberculosis. Am J Respir Crit Care Med 1996; 154: 1478–83.
  • Central Statistics Authority. 1994 population and housing census of Ethiopia. Addis Ababa: Central Statistics Authority, 1998.
  • Ministry of Health of Ethiopia. National tuberculosis and leprosy control programme. Annual programme review report. Addis Ababa: Ministry of Health, 1999.
  • Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivty tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21–43.
  • WHO/UNAIDS Joint Program on HIV/AIDS. Revised recommendation for selection and use of HIV antibody tests. Weekly Epidemiol 1997; 72: 81–2.
  • Nkengasong J, Kerckhoven V, Carpels G, et al. HIV screening and confirmation: A simple and less expensive testing algorithm. Ann Soc Belg Med Trop 1992; 72: 129–39.
  • World Health Organisation. Guidelines for surveillance of drug resistance in tuberculosis. Geneva: WHO, 1994.
  • Kochi A, Vareldzis B, Styblo K. Multi drug resistance tuberculosis and its control. Res Microbiol 1993; 144: 104–10.
  • Dean AG, Dean JA, Coulombier D, et al. Epi Info, Version 6. Atlanta, GA: Centres for Disease Control and Prevention, 1995.
  • SPSS Base 7.5 for Windows user’s guide. Chicago, IL: SPSS Inc., 1997.
  • O’Brien RJ. Drug resistance tuberculosis: aetiology, management and prevention. Semin Respir Med 1994; 9: 104–12.
  • Spellman CW, Matty KJ, Weis SE. A survey of drug resistant Mycobacterium tuberculosis and its relationship to HIV infection. AIDS 1998; 12: 191–5.
  • Karstaed AS, Jones N, Khoosal M, Crewe-Brown HH. The bacteriology of pulmonary tuberculosis in a population with high human immunodeficiency virus sero-prevalence. Int J Tuberc Lung Dis 1998; 2: 312–6.
  • Kenyon TA, Mwasenkaga MJ, Huebner R, et al. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immune deficiency virus co-epidemics in Botswana. Int J Tuberc Lung Dis 1999; 3: 4–11.
  • Salomon N, Perlman DC, Depalo VA, et al. Drug resistant tuberculosis: Factors associated with rise in resistance in an urban population. Mt Sinai J Med 1994; 61: 341–8.
  • Salomon N, Perlman DC, Friedmann P, et al. Predictors and outcome of multi-drug-resistant tuberculosis. Clin Infect Dis 1995; 21: 1245–52.
  • Demissie M, Kebede D. Defaulting from tuberculosis treatment in Addis Ababa tuberculosis centre and factors associated with it. Ethiop Med J 1994; 32: 97–106.
  • Bradford ZW, Martin JN, Reingold LA, et al. The changing epidemiology of acquired drug resistant tuberculosis in San-Francisco, USA. Lancet 1996; 348: 928–31.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.